(Q33148990)

22 July 2017

1 reference

title

Brugada syndrome: 1992-2002: a historical perspective (English)

1 reference

22 July 2017

0 references

1

2

object named as

Charles Antzelevitch

1 reference

22 July 2017

6

Jeffrey A Towbin

1 reference

22 July 2017

3

Pedro Brugada

1 reference

22 July 2017

Josep Brugada

4

1 reference

ORCID Public Data File 2021

Ramon Brugada

series ordinal

5

object named as

Ramon Brugada

1 reference

22 July 2017

Kolawanee Nademanee

7

1 reference

22 July 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Journal of the American College of Cardiology

22 July 2017

published in

1 reference

22 July 2017

volume

41

1 reference

22 July 2017

issue

10

1 reference

22 July 2017

page(s)

1665-1671

1 reference

Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome

22 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Cellular basis for the electrocardiographic J wave

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Familial occurrence of electrocardiographic abnormalities of the Brugada-type

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Ventricular fibrillation without apparent heart disease: description of six cases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Right bundle branch block, right precordial st-segment elevation, and sudden death in young people.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Molecular genetic basis of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

1 reference

7 January 2021

Localized right ventricular morphological abnormalities detected by electron-beam computed tomography represent arrhythmogenic substrates in patients with the Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Brugada syndrome: historical perspectives and observations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Late potentials and the Brugada syndrome**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome: using the epicardial lead

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Genetic basis and molecular mechanism for idiopathic ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

The Brugada syndrome: ionic basis and arrhythmia mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Natural history of Brugada syndrome: insights for risk stratification and management

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

The cardiac sodium channel: gating function and molecular pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Fever and Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Sodium channel block produces opposite electrophysiological effects in canine ventricular epicardium and endocardium.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Flecainide-induced arrhythmia in canine ventricular epicardium. Phase 2 reentry?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

The Brugada syndrome: clinical, electrophysiologic and genetic aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Brugada syndrome: a decade of progress

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Proposed diagnostic criteria for the Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Proposed diagnostic criteria for the Brugada syndrome: consensus report

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

"Brugada" syndrome: clinical data and suggested pathophysiological mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Arrhythmia induction by antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Tricyclic antidepressants and the Brugada syndrome: an example of Brugada waves appearing after the administration of desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Overdose of cyclic antidepressants and the Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Transient ST segment elevation in right precordial leads induced by psychotropic drugs: relationship to the Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Brugada syndrome mimicked by tricyclic antidepressant overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Asymptomatic brugada syndrome case unmasked during dimenhydrinate infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Aborted sudden death, transient Brugada pattern, and wide QRS dysrrhythmias after massive cocaine ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Wolff-Parkinson-White syndrome associated with Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Pharmacological and device approach to therapy of inherited cardiac diseases associated with cardiac arrhythmias and sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Infant case with a malignant form of Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Successful prevention of recurrent ventricular fibrillation by intravenous isoproterenol in a patient with Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

The Brugada syndrome: is an implantable cardioverter defibrillator the only therapeutic option?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900310-3

7 January 2021

10.1016/S0735-1097(03)00310-3

Identifiers

DOI

1 reference

22 July 2017

1 reference